\nRocket Lab USA, Inc. (Nasdaq: RKLB) (\u201cRocket Lab\u201d or \u201cthe Company\u201d), a global leader in launch services and space systems, today announced it has completed and shipped a custom Photon spacecraft developed for Varda Space Industries (\u201cVarda\u201d), a leading in-space manufacturing and hypersonic re-entry logistics company.<\/p>\n
This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230509005556\/en\/<\/a><\/p>\n Rocket Lab’s Photon spacecraft integrated with Varda Space Industry’s in-space manufacturing capsule. (Photo: Business Wire)<\/p>\n<\/div>\n \nThe Rocket Lab-designed and built Photon spacecraft will provide power, communications, propulsion, and attitude control to Varda\u2019s 120kg capsule that will produce pharmaceutical products in microgravity and return them to Earth. In addition to providing support during the in-space manufacturing phase of Varda\u2019s mission, the Photon will place Varda\u2019s hypersonic re-entry capsule (carrying finished pharmaceuticals on board) on a return trajectory to Earth. Varda\u2019s space-manufactured products are targeting small molecule therapeutics, and over time larger molecules and biologics \u2014 all of which can have higher efficacy when produced in microgravity, while the re-entry capsule provides opportunities to advance hypersonic systems. This first mission will focus on small molecule formulation to provide insight into retrieved microgravity-grown pharmaceutical crystals, particularly the antiretroviral Ritonavir, an active ingredient in the COVID medication Paxlovid also used in the treatment of Human Immunodeficiency Virus (HIV).<\/p>\n \nThe Photon spacecraft was developed, manufactured, and tested at Rocket Lab\u2019s Spacecraft Production Facility in Long Beach, California. With final assembly, integration, and test of the spacecraft complete, the fully integrated Varda spacecraft has been shipped to Vandenberg Space Force Base for launch on a commercial rideshare mission scheduled for no earlier than June 8.<\/p>\n \nThis Photon spacecraft is the first of four ordered by Varda to support in-space pharmaceutical manufacturing. Leveraging Rocket Lab\u2019s deep vertical integration, all Photon spacecraft incorporate Rocket Lab-designed and manufactured components and software including star trackers, propulsion, reaction wheels, solar panels, flight software, radios, composite structures and tanks, and separation systems.<\/p>\n \n\u201cOpening access to space is about much more than launch for Rocket Lab. It\u2019s about making it easier to put the ideas of tomorrow in orbit today, enabling innovation, rapid iteration, and new capabilities that will improve lives back on Earth. This is exactly what the team at Varda is doing by producing novel pharmaceuticals in orbit and we\u2019re immensely proud to make that possible with our Photon spacecraft,\u201d said Rocket Lab founder and CEO, Peter Beck. \u201cSpace Systems is a rapidly growing part of Rocket Lab\u2019s business, and we\u2019re delighted to deliver another spacecraft that leverages our vertical integration strategy for high-quality and cost-effective satellite solutions on rapid timelines.\u201d<\/p>\n \n\u201cRocket Lab has been an asset in developing and delivering this spacecraft on our schedule and budget,\u201d said Varda Space Industries Chief Executive Officer, Will Bruey. \u201cOur engineers at Varda and the Rocket Lab team have worked together seamlessly and are excited by the benefits this spacecraft will bring to Earth and healthcare.\u201d<\/p>\n \nRocket Lab\u2019s Photon spacecraft is a configurable spacecraft bus platform that can support a range of missions \u2013 from low Earth orbit to interplanetary destinations. A high energy variant of Photon was developed and launched by Rocket Lab in 2022, successfully deploying the CAPSTONE spacecraft to lunar orbit for NASA.<\/p>\n About Rocket Lab<\/b><\/p>\n \nFounded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, the Photon satellite platform, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab\u2019s Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 161 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab\u2019s Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. To learn more, visit www.rocketlabusa.com<\/a>.<\/p>\n FORWARD-LOOKING STATEMENTS<\/b><\/p>\n \nThis press release may contain certain \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on Rocket Lab\u2019s current expectations and beliefs concerning future developments and their potential effects. These forward-looking statements involve a number of risks, uncertainties (many of which are beyond Rocket Lab\u2019s control), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including risks related to the global COVID-19 pandemic; risks related to government restrictions and lock-downs in New Zealand and other countries in which we operate that could delay or suspend our operations; delays and disruptions in expansion efforts; our dependence on a limited number of customers; the harsh and unpredictable environment of space in which our products operate which could adversely affect our launch vehicle and spacecraft; increased congestion from the proliferation of low Earth orbit constellations which could materially increase the risk of potential collision with space debris or another spacecraft and limit or impair our launch flexibility and\/or access to our own orbital slots; increased competition in our industry due in part to rapid technological development and decreasing costs; technological change in our industry which we may not be able to keep up with or which may render our services uncompetitive; average selling price trends; failure of our launch vehicles, spacecraft and components to operate as intended either due to our error in design in production or through no fault of our own; launch schedule disruptions; supply chain disruptions, product delays or failures; design and engineering flaws; launch failures; natural disasters and epidemics or pandemics; changes in governmental regulations including with respect to trade and export restrictions, or in the status of our regulatory approvals or applications; or other events that force us to cancel or reschedule launches, including customer contractual rescheduling and termination rights; risks that acquisitions may not be completed on the anticipated time frame or at all or do not achieve the anticipated benefits and results; and the other risks detailed from time to time in Rocket Lab\u2019s filings with the Securities and Exchange Commission (the \u201cSEC\u201d), including under the heading \u201cRisk Factors\u201d in Rocket Lab\u2019s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 7, 2023, and elsewhere (including that the impact of the COVID-19 pandemic may also exacerbate the risks discussed therein). There can be no assurance that the future developments affecting Rocket Lab will be those that we have anticipated. Except as required by law, Rocket Lab is not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.<\/p>\n View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230509005556\/en\/<\/a><\/span><\/p>\n \nRocket Lab Media Contact KEYWORDS:<\/b> California United States North America<\/p>\n INDUSTRY KEYWORDS:<\/b> Technology Satellite Other Technology Aerospace Manufacturing Hardware Health Pharmaceutical General Health<\/p>\n![\"Rocket](\"https:\/\/mms.businesswire.com\/media\/20230509005556\/en\/1787613\/4\/Rocket_Lab_Photon_Spacecraft_for_Varda_Space_Industries.jpg\")
<\/p>\n<\/p>\n
\n
Morgan Bailey
\n
media@rocketlabusa.com<\/a><\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20230509005556\/en\/1417605\/3\/Rocket_Lab_Logo.jpg\"){kind=logo}
<\/td>\n<\/tr>\n![\"Photo\"](\"https:\/\/mms.businesswire.com\/media\/20230509005556\/en\/1787613\/3\/Rocket_Lab_Photon_Spacecraft_for_Varda_Space_Industries.jpg\")
<\/td>\n<\/tr>\n